"10.1371_journal.pone.0064947","plos one","2013-06-04T00:00:00Z","Johannes M Hennings; Martin A Kohli; Darina Czamara; Maria Giese; Anne Eckert; Christiane Wolf; Angela Heck; Katharina Domschke; Volker Arolt; Bernhard T Baune; Sonja Horstmann; Tanja Brückl; Torsten Klengel; Andreas Menke; Bertram Müller-Myhsok; Marcus Ising; Manfred Uhr; Susanne Lucae","Max-Planck-Institute of Psychiatry, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Clinics Basel, Basel, Switzerland; Department of Psychiatry, University of Wuerzburg, Wuerzburg, Germany; Department of Psychiatry, University of Muenster, Muenster, Germany; Department of Psychiatry, The University of Adelaide, Eleanor Harrald Building, Royal Adelaide Hospital, Adelaide, Australia","Conceived and designed the experiments: JH MK SL. Performed the experiments: JH TB SH TK SL AM MG AE MU. Analyzed the data: JH DC CW AH MI BM. Contributed reagents/materials/analysis tools: KD VA BB MG AE. Wrote the paper: JH SL.","The authors have the following interests. Arolt is member of advisory boards and/or gave presentations for the following companies: Astra-Zeneca, Janssen-Organon, Eli Lilly, Lundbeck, Pfizer, Servier, and Wyeth. He also received grants from Astra-Zeneca, Lundbeck, and Wyeth. He chaired the committee for the “Wyeth Research Award Depression and Anxiety”. Czamara was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). Domschke has received speaker fees from Pfizer, Lilly and Bristol-Myers Squibb; she is a consultant for Johnson & Johnson and has received funding by Astra Zeneca. Hennings has received travel support to scientific congresses from Eli Lilly, Bayer Vital and Novartis. Menke, Holsboer inventors: Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (TESI). European application number: 08016477.5. International application number: PCT/EP2009/061575. Uhr is patent holder of WO2005/108605A2 and WO2008/151803A2. Katharina Domschke is a PLOS ONE Editorial Board member. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","06","Johannes M Hennings","JMH",18,TRUE,3,9,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
